M. Belvisi (London, United Kingdom), M. Cazzola (Roma, Rm, Italy)
Late Breaking Abstract - Functional respiratory imaging (FRI) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using novel Co-Suspension Delivery Technology (GFF MDI) in COPD W. De Backer (Edegem (Antwerp), Belgium)
| |
CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs D. Miglietta (PARMA, PR, Italy)
| |
A randomized placebo controlled trial of AZD8999 (LAS190792) a novel dual acting bronchodilator in asthmatics C. Astbury (Barcelona, Spain)
| |
Protein tyrosin kinase and KCa++ cannel: two faces of the same coin in LABA/LAMA synergy L. Calzetta (Roma, Rm, Italy)
| |
Secondary allosteric M3 receptor binding for tiotropium: implications for bronchoprotection and functional interactions with LABAs R. Gosens (Groningen, Netherlands)
| |
The antitussive effects of alpha7 (a7) nicotinic receptor agonists P. Dicpinigaitis (New York, United States of America)
| |
Activation of transient receptor potential (TRP) channels by hypoosmolar solution: an endogenous mechanism of ATP release and afferent nerve activation S. Bonvini (London, United Kingdom)
| |
TRPM3, P2X2 and P2X3 expression patterns in single airway sensory nerves M. Wortley (London, United Kingdom)
| |